HILLSBORO, OR, UNITED STATES, January 15, 2025 /EINPresswire.com/ -- The Children’s Cancer Therapy Development Institute (cc-TDI) is proud to announce a new publication, DNA methylation patterns are influenced by Pax3::Foxo1 expression and developmental …
The Children's Cancer Therapy Development Institute has been awarded $222,120 by the Megan's Mission Foundation to advance three clinical research initiatives. HILLSBORO, OR, UNITED STATES, September 30, 2024 /EINPresswire.com/ -- The Children’s …
Children’s Cancer Therapy Development Institute highlights potential of entinostat as a combinatorial therapy for rhabdomyosarcoma HILLSBORO, OR, UNITED STATES, August 17, 2024 /EINPresswire.com/ -- In a groundbreaking study published today in …
Former Intel Executive, Claire Newman, takes post as the new Executive Director of the Children’s Cancer Therapy Development Institute. HILLSBORO, OREGON, UNITED STATES, July 13, 2024 /EINPresswire.com/ -- The Children’s Cancer Therapy Development …
HILLSBORO, OREGON, UNITED STATES, April 2, 2024 /EINPresswire.com/ -- The Children’s Cancer Therapy Development Institute (cc-TDI), proudly announces a global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the …
HILLSBORO, OR, UNITED STATE, March 15, 2024 /EINPresswire.com/ -- In a significant stride towards advancing pediatric cancer research, the state of Oregon has allocated a generous $1 million grant to the Children’s Cancer Therapy Development Institute ( …
HILLSBORO, OR, UNITED STATES, March 6, 2024 /EINPresswire.com/ -- The Children’s Cancer Therapy Development Institute (cc-TDI) proudly announces its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global …
HILLSBORO, OREGON, UNITED STATES, January 9, 2024 /EINPresswire.com/ -- The Children’s Cancer Therapy Development Institute was awarded $100,000 in continued support of two research studies for Rhabdomyosarcoma (RMS) by the Megan’s Mission Foundation. …
Megan Bugg's legacy furthers Rhabdomyosarcoma research at the Children's Cancer Therapy Development Institute in hopes of better outcomes for children. HILLSBORO, OREGON, USA, October 3, 2023 /EINPresswire.com/ -- The Children’s Cancer Therapy …
This study canvased 640,000 potential drugs and drug-like compounds for RMS and Azelnidipine, a DHP drug, was chosen as the lead candidate for further testing. HILLSBORO, OR, UNITED STATES, May 25, 2023 /EINPresswire.com/ -- The scientific team at the …
cc-TDI's new Silicon Forest-based laboratory offers state-of-the-art facilities that allow for the expansion of preclinical research on rare childhood cancers. HILLSBORO, OREGON, UNITED STATES, April 28, 2023 /EINPresswire.com/ -- The Children’s …
LANDMARK INTERNATIONAL COLLABORATION CREATES A FOUNDATION FOR DRUG DEVELOPMENT IN YOUNG ADULT CANCER CALLED CCS, OPENING THE DOOR TO NEW POTENTIAL THERAPY THE SILICON FOREST, HILLSBORO, OREGON, USA, March 23, 2023 /EINPresswire.com/ -- Researchers at …
The Children’s Cancer Therapy Development Institute was awarded $100,000 for groundbreaking Rhabdomyosarcoma research by the Megan’s Mission Foundation. BEAVERTON, OREGON, UNITED STATES, February 11, 2023 /EINPresswire.com/ -- The Children’s Cancer …
BEAVERTON, OREGON, UNITED STATES, January 9, 2023 /EINPresswire.com/ -- The Children’s Cancer Therapy Development Institute (cc-TDI) awarded $100,000 in support in support of Diffuse Intrinsic Pontine Glioma (DIPG) research by The Lyla Nsouli Foundation …
Researchers have developed the first genetically-engineered mice containing the Pax7-Foxo1 gene fusion found in some forms of alveolar rhabdomyosarcoma. BEAVERTON, OR, UNITED STATES, November 14, 2022 /EINPresswire.com/ -- Children’s Cancer Therapy …
BEAVERTON, OREGON, UNITED STATES, July 19, 2022 /EINPresswire.com/ -- Children’s Cancer Therapy Development Institute (cc-TDI) Biomedical Engineer Samuel Rasmussen led a study with global collaboration published in the journal, Clinical and Translational …
